2025. Toxicity and Safety of Induction Chemotherapy in Locally Advanced Oropharynx, Hypopharynx and Larynx: Non-Randomized Study Comparing DCF and Immunochemotherapy (ICT) with PF-Pembrolizumab. Voprosy onkologii. 70, 6 (Jan. 2025), 1096–1105. DOI:https://doi.org/10.37469/0507-3758-2024-70-6-1096-1105.